A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT.

Gary George WhitlockSarah FidlerAmanda ClarkeSujin KangArnold XhikolaAna MilinkovicAlfredo Soler-CarracedoMerle HendersonTanya AdamsIshrat JahanAkif KhawajaGraham TaylorMarta Boffito

Published in: HIV research & clinical practice (2024)

In this first head-to-head study in the context of ART initiation, HIV RNA decline from baseline to week 12 was significantly more rapid for BIC/F/TAF compared with DRV/c/F/TAF.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv testing
hiv aids
hepatitis c virus
clinical trial
men who have sex with men
optic nerve
double blind
randomized controlled trial
quantum dots
nucleic acid